Acciones Parnell Pharmaceuticals Holdings Ltd Nasdaq
Acciones
AU0000XINEU9
Farmacéuticos
Ventas 2020 | 30 M 19,82 M 18,42 M | Ventas 2021 | 34,17 M 22,58 M 20,98 M | Capitalización | 4,08 mil 2,7 mil 2,51 mil |
---|---|---|---|---|---|
Resultado Neto 2020 | -15 M -9,91 M -9,21 M | Resultado Neto 2021 | -1 M -661 mil -614 mil | VE / Ventas 2020 | 2,18 x |
Deuda neta 2020 | 56,16 M 37,11 M 34,48 M | Deuda neta 2021 | 58,89 M 38,92 M 36,16 M | VE / Ventas 2021 | 1,72 x |
P/E ratio 2020 |
-0,56
x | P/E ratio 2021 |
-
| Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/02/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/12/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,35 % | 76,23 mil M | |
-9,19 % | 6669,88 M | |
+24,75 % | 3698,41 M | |
-1,11 % | 3205,25 M | |
+6,08 % | 1518,66 M | |
-15,13 % | 1373,3 M | |
-25,63 % | 1244,51 M | |
-7,62 % | 1205,72 M | |
-10,84 % | 1170,41 M |